Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to -$0.34.

  • Pulmonx's EPS (Basic) rose 555.56% to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.41, marking a year-over-year increase of 408.16%. This contributed to the annual value of -$1.44 for FY2024, which is 988.17% up from last year.
  • According to the latest figures from Q3 2025, Pulmonx's EPS (Basic) is -$0.34, which was up 555.56% from -$0.38 recorded in Q2 2025.
  • In the past 5 years, Pulmonx's EPS (Basic) registered a high of -$0.28 during Q3 2021, and its lowest value of -$0.43 during Q1 2022.
  • For the 5-year period, Pulmonx's EPS (Basic) averaged around -$0.37, with its median value being -$0.36 (2021).
  • Per our database at Business Quant, Pulmonx's EPS (Basic) soared by 9414.63% in 2021 and then crashed by 3571.43% in 2022.
  • Over the past 5 years, Pulmonx's EPS (Basic) (Quarter) stood at -$0.36 in 2021, then dropped by 5.56% to -$0.38 in 2022, then increased by 5.26% to -$0.36 in 2023, then grew by 6.7% to -$0.34 in 2024, then fell by 1.22% to -$0.34 in 2025.
  • Its EPS (Basic) stands at -$0.34 for Q3 2025, versus -$0.38 for Q2 2025 and -$0.36 for Q1 2025.